StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Nu-Med Plus shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Nu-Med Plus's shares outstanding was 84M at Jun 30, 2026. For fiscal 2025 it was 84M, up 0.0% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is 84M in fiscal 2024.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202584M0.0%
FY2024Dec 31, 202484M+2.3%
FY2023Dec 31, 202382M+2.2%
FY2022Dec 31, 202280M+9.0%
FY2021Dec 31, 202173M+34.6%
FY2020Dec 31, 202055M+19.7%
FY2019Dec 31, 201946M+9.0%
FY2018Dec 31, 201842M-41.9%
FY2017Dec 31, 201772M-4.2%
FY2016Dec 31, 201675M+112.0%
FY2015Dec 31, 201535M+8.0%
FY2014Dec 31, 201433M+17.9%
FY2013Dec 31, 201328M+22.9%
FY2012Dec 31, 201223M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202684M0.0%
Q1 FY2026Mar 31, 202684M0.0%
Q4 FY2025Dec 31, 202584M0.0%
Q3 FY2025Sep 30, 202584M0.0%
Q2 FY2025Jun 30, 202584M0.0%
Q1 FY2025Mar 31, 202584M0.0%
Q4 FY2024Dec 31, 202484M+1.1%
Q3 FY2024Sep 30, 202484M+2.7%
Q2 FY2024Jun 30, 202484M+2.7%
Q1 FY2024Mar 31, 202484M+2.7%
Q4 FY2023Dec 31, 202383M+1.6%
Q3 FY2023Sep 30, 202381M+2.0%
Q2 FY2023Jun 30, 202381M+2.5%
Q1 FY2023Mar 31, 202381M+2.5%
Q4 FY2022Dec 31, 202281M+46.5%
Q3 FY2022Sep 30, 202280M+0.5%
Q2 FY2022Jun 30, 202279M0.0%
Q1 FY2022Mar 31, 202279M+0.1%
Q4 FY2021Dec 31, 202156M-23.6%
Q3 FY2021Sep 30, 202179M+57.9%
Q2 FY2021Jun 30, 202179M+67.6%
Q1 FY2021Mar 31, 202179M+70.3%
Q4 FY2020Dec 31, 202073M+58.2%
Q3 FY2020Sep 30, 202050M+9.4%
Q2 FY2020Jun 30, 202047M+4.4%
Q1 FY2020Mar 31, 202047M+12.3%
Q4 FY2019Dec 31, 201946M-12.6%
Q3 FY2019Sep 30, 201946M+17.7%
Q2 FY2019Jun 30, 201945M+19.9%
Q1 FY2019Mar 31, 201941M+10.4%
Q4 FY2018Dec 31, 201853M+53.6%
Q3 FY2018Sep 30, 201839M-48.2%
Q2 FY2018Jun 30, 201838M–
Q1 FY2018Mar 31, 201838M–
Q2 FY2017Jun 30, 201734M–
Q1 FY2017Mar 31, 201775M–

More Nu-Med Plus figures

See a number that looks wrong?